Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

SPC-15 combination treatment shows enhanced efficacy in combating stress-induced psychiatric disordersSARASOTA, FL, Feb. 18, 2025 (GLOBE ...

Chemical process enhances room temperature stability - - Provisional patent applications filed -PURCHASE, N.Y., Feb. 20, 2025 (GLOBE ...

Acurx Pharmaceuticals’ DNA Polymerase IIIC Inhibitors receives Japanese patent: Staten Island, New York Thursday, February 20, 2025, 18:00 Hrs [IST] Acurx Pharmaceuticals, Inc., ...

Pharma consultant Sanjay Agrawal seeks patent for a new drug formulation targeting cellular ageing, aiming to improve skin health, energy, and vitality.

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...

A group of health insurers has filed a lawsuit against Corcept Therapeutics (NASDAQ:CORT) in California, accusing the rare ...

In the backdrop of the US-India dialogue on tariffs, the Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian ...

The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

There are two significant, nonscientific obstacles – a shortage of funding and patent law – that will require concerted effort by scientists, concerned citizens, society and our lawmakers to overcome.

One particular issue in pharmaceutical patent law, 'reach-through' claims ... Rather than changing the FDA approval process, a fundamental shift in the incentives toward breakthrough drugs and ...